RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Evaluation of the Expression of the Inhibitor of Apoptosis Protein Family and Human Telomerase Reverse Transcriptase in Patients With Advanced Colorectal Adenoma

      한글로보기

      https://www.riss.kr/link?id=A103553067

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background: It has been reported that the expression of the inhibitor of apoptosis protein (IAP) family increases in patients with colon cancer. We evaluated the expression of the IAP family and human telomerase reverse transcriptase (hTERT) in normal colon mucosa from patients with advanced colorectal adenoma and investigated their features according to characteristics of advanced colorectal adenoma.
      Methods: While resections of polyps were performed in patients (n = 80) diagnosed with advanced colorectal adenoma or carcinoma in situ, additional normal tissues were obtained from the sigmoid colon. In healthy patients (n = 16), blind biopsies were performed on the sigmoid colon. The expression of the IAP family, including survivin, XIAP, cIAP1, and cIAP2, and hTERT, were analyzed by real-time PCR in both groups.
      Results: A total of 80 advanced colorectal adenoma patients (71.3% male, mean age of 60.4 years) and 16 control patients were enrolled in this study. The mean ranking of cIAP2 was higher in the control group (68.88 vs. 44.43, P = 0.001). The expression levels of hTERT, survivin, XIAP, and cIAP from both groups showed no differences. The expression of survivin, XIAP, cIAP1, cIAP2, and hTERT depending on certain factors of advanced adenoma, including the number (two or fewer vs. three or more), size (smaller than 1 cm vs. larger than 1 cm), grade of dysplasia (low grade adenoma vs. high grade adenoma), pathology (tubular adenoma vs. villous adenoma), and presence of endometrial intraepithelial neoplasms, showed no significant correlations in the Mann-Whitney U-test.
      Conclusions: The expression of the IAP family and hTERT, except cIAP2, in the normal mucosa of patients with advanced colorectal adenoma were not different from those of the control group. There were no differences in the IAP family and hTERT according to the characteristics of advanced adenoma.
      번역하기

      Background: It has been reported that the expression of the inhibitor of apoptosis protein (IAP) family increases in patients with colon cancer. We evaluated the expression of the IAP family and human telomerase reverse transcriptase (hTERT) in normal...

      Background: It has been reported that the expression of the inhibitor of apoptosis protein (IAP) family increases in patients with colon cancer. We evaluated the expression of the IAP family and human telomerase reverse transcriptase (hTERT) in normal colon mucosa from patients with advanced colorectal adenoma and investigated their features according to characteristics of advanced colorectal adenoma.
      Methods: While resections of polyps were performed in patients (n = 80) diagnosed with advanced colorectal adenoma or carcinoma in situ, additional normal tissues were obtained from the sigmoid colon. In healthy patients (n = 16), blind biopsies were performed on the sigmoid colon. The expression of the IAP family, including survivin, XIAP, cIAP1, and cIAP2, and hTERT, were analyzed by real-time PCR in both groups.
      Results: A total of 80 advanced colorectal adenoma patients (71.3% male, mean age of 60.4 years) and 16 control patients were enrolled in this study. The mean ranking of cIAP2 was higher in the control group (68.88 vs. 44.43, P = 0.001). The expression levels of hTERT, survivin, XIAP, and cIAP from both groups showed no differences. The expression of survivin, XIAP, cIAP1, cIAP2, and hTERT depending on certain factors of advanced adenoma, including the number (two or fewer vs. three or more), size (smaller than 1 cm vs. larger than 1 cm), grade of dysplasia (low grade adenoma vs. high grade adenoma), pathology (tubular adenoma vs. villous adenoma), and presence of endometrial intraepithelial neoplasms, showed no significant correlations in the Mann-Whitney U-test.
      Conclusions: The expression of the IAP family and hTERT, except cIAP2, in the normal mucosa of patients with advanced colorectal adenoma were not different from those of the control group. There were no differences in the IAP family and hTERT according to the characteristics of advanced adenoma.

      더보기

      참고문헌 (Reference)

      1 Shay JW, "The reactivation of telomerase activity in cancer progression" 12 : 129-131, 1996

      2 Hunter AM, "The inhibitors of apoptosis (IAPs) as cancer targets" 12 : 1543-1568, 2007

      3 Altieri DC, "The case for survivin as a regulator of microtubule dynamics and cell-death decisions" 18 : 609-615, 2006

      4 Greider CW, "Telomeres, telomerase and cancer" 274 : 92-97, 1996

      5 Kanamaru T, "Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer" 10 : 205-210, 2002

      6 Kim NW, "Specific association of human telomerase activity with immortal cells and cancer" 266 : 2011-2015, 1994

      7 Saleh S, "Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer" 40 : 25-30, 2008

      8 Qi G, "Intracellular localization of survivin determines biological behavior in colorectal cancer" 22 : 557-562, 2009

      9 Smolewski P, "Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies" 11 : 633-649, 2011

      10 Miura K, "Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer" 41 : 175-182, 2011

      1 Shay JW, "The reactivation of telomerase activity in cancer progression" 12 : 129-131, 1996

      2 Hunter AM, "The inhibitors of apoptosis (IAPs) as cancer targets" 12 : 1543-1568, 2007

      3 Altieri DC, "The case for survivin as a regulator of microtubule dynamics and cell-death decisions" 18 : 609-615, 2006

      4 Greider CW, "Telomeres, telomerase and cancer" 274 : 92-97, 1996

      5 Kanamaru T, "Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer" 10 : 205-210, 2002

      6 Kim NW, "Specific association of human telomerase activity with immortal cells and cancer" 266 : 2011-2015, 1994

      7 Saleh S, "Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer" 40 : 25-30, 2008

      8 Qi G, "Intracellular localization of survivin determines biological behavior in colorectal cancer" 22 : 557-562, 2009

      9 Smolewski P, "Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies" 11 : 633-649, 2011

      10 Miura K, "Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer" 41 : 175-182, 2011

      11 Varfolomeev E, "IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis" 131 : 669-681, 2007

      12 Torre LA, "Global cancer statistics, 2012" 65 : 87-108, 2015

      13 Kempkensteffen C, "Expression parameters of the inhibitors of apoptosis cIAP1 and cIAP2 in renal cell carcinomas and their prognostic relevance" 120 : 1081-1086, 2007

      14 Xiang G, "Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis" 100 : 708-712, 2009

      15 Vischioni B, "Expression and localization of inhibitor of apoptosis proteins in normal human tissues" 37 : 78-86, 2006

      16 Boldrini L, "Evaluation of telomerase mRNA (hTERT) in colon cancer" 21 : 493-497, 2002

      17 Karasawa H, "Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells" 100 : 903-913, 2009

      18 Vogt PK, "Cancer genes" 158 : 273-278, 1993

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2022 평가예정 재인증평가 신청대상 (재인증)
      2019-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2018-12-01 평가 등재후보로 하락 (계속평가) KCI등재후보
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2013-10-14 학술지명변경 외국어명 : Cancer Prevention Research -> Journal of Cancer Prevention KCI등재
      2012-10-15 학회명변경 영문명 : Korean Association of Cancer Prevention -> Korean Society of Cancer Preveniton KCI등재
      2011-04-04 학술지명변경 외국어명 : Journal of Korean Association of Cancer Prevention -> Cancer Prevention Research KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2007-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.22 0.22 0.18
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.15 0.12 0.405 0.13
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼